telmisartan has been researched along with 3-nitropropionic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Rasheed, NO; Ibrahim, WW | 1 |
| Ahmed, MAE; El Sayed, NS; El-Sahar, AE; Mansour, RM | 1 |
2 other study(ies) available for telmisartan and 3-nitropropionic acid
| Article | Year |
|---|---|
Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: Cross talk between PPAR-γ and PI3K/Akt/GSK-3β pathway.
Topics: Animals; Glycogen Synthase Kinase 3 beta; Humans; Huntington Disease; Neuroprotective Agents; Nitro Compounds; Phosphatidylinositol 3-Kinases; PPAR gamma; Propionates; Proto-Oncogene Proteins c-akt; Rats; Telmisartan | 2022 |
Addressing Peroxisome Proliferator-Activated Receptor-gamma in 3-Nitropropionic Acid-Induced Striatal Neurotoxicity in Rats.
Topics: Animals; Glycogen Synthase Kinase 3 beta; Nitro Compounds; Pioglitazone; PPAR gamma; Propionates; Rats; Telmisartan | 2022 |